NO860952L - Fremgangsmaate for visualisering av en arterie-sirkulasjon og middel for utfoerelse av denne. - Google Patents
Fremgangsmaate for visualisering av en arterie-sirkulasjon og middel for utfoerelse av denne.Info
- Publication number
- NO860952L NO860952L NO860952A NO860952A NO860952L NO 860952 L NO860952 L NO 860952L NO 860952 A NO860952 A NO 860952A NO 860952 A NO860952 A NO 860952A NO 860952 L NO860952 L NO 860952L
- Authority
- NO
- Norway
- Prior art keywords
- microspheres
- stated
- ray
- biodegradable
- rays
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 32
- 230000004087 circulation Effects 0.000 title claims description 12
- 210000001367 artery Anatomy 0.000 title description 3
- 239000004005 microsphere Substances 0.000 claims description 95
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 claims description 24
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 20
- 239000000463 material Substances 0.000 claims description 14
- ZEYOIOAKZLALAP-UHFFFAOYSA-M sodium amidotrizoate Chemical compound [Na+].CC(=O)NC1=C(I)C(NC(C)=O)=C(I)C(C([O-])=O)=C1I ZEYOIOAKZLALAP-UHFFFAOYSA-M 0.000 claims description 9
- 239000011358 absorbing material Substances 0.000 claims description 8
- 210000004369 blood Anatomy 0.000 claims description 8
- 239000008280 blood Substances 0.000 claims description 8
- 239000000126 substance Substances 0.000 claims description 8
- 238000010438 heat treatment Methods 0.000 claims description 6
- 102000008100 Human Serum Albumin Human genes 0.000 claims description 5
- 108091006905 Human Serum Albumin Proteins 0.000 claims description 5
- 230000015271 coagulation Effects 0.000 claims description 5
- 238000005345 coagulation Methods 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims description 4
- 235000012343 cottonseed oil Nutrition 0.000 claims description 4
- 239000002385 cottonseed oil Substances 0.000 claims description 4
- 238000004132 cross linking Methods 0.000 claims description 4
- 239000003208 petroleum Substances 0.000 claims description 4
- 238000012800 visualization Methods 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 238000007711 solidification Methods 0.000 claims description 3
- 230000008023 solidification Effects 0.000 claims description 3
- 210000004072 lung Anatomy 0.000 description 30
- 102000009027 Albumins Human genes 0.000 description 18
- 108010088751 Albumins Proteins 0.000 description 18
- 208000010378 Pulmonary Embolism Diseases 0.000 description 11
- 210000004204 blood vessel Anatomy 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- 239000003921 oil Substances 0.000 description 10
- 235000019198 oils Nutrition 0.000 description 10
- 230000002285 radioactive effect Effects 0.000 description 10
- 238000002347 injection Methods 0.000 description 7
- 239000007924 injection Substances 0.000 description 7
- 230000005855 radiation Effects 0.000 description 6
- 238000003745 diagnosis Methods 0.000 description 5
- 210000002216 heart Anatomy 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 210000002565 arteriole Anatomy 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 210000003462 vein Anatomy 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 230000002093 peripheral effect Effects 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 208000005189 Embolism Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 238000002594 fluoroscopy Methods 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 210000001147 pulmonary artery Anatomy 0.000 description 2
- 230000002685 pulmonary effect Effects 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 239000003517 fume Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 238000010907 mechanical stirring Methods 0.000 description 1
- 230000002969 morbid Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- -1 polyethylene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000004088 pulmonary circulation Effects 0.000 description 1
- 239000012857 radioactive material Substances 0.000 description 1
- 210000005245 right atrium Anatomy 0.000 description 1
- 210000005241 right ventricle Anatomy 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
- A61K49/0414—Particles, beads, capsules or spheres
- A61K49/0419—Microparticles, microbeads, microcapsules, microspheres, i.e. having a size or diameter higher or equal to 1 micrometer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1658—Proteins, e.g. albumin, gelatin
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/90—In vivo diagnostic or in vivo test agent which contains an additional ingredient to reduce the toxicity or side effects of the active ingredient
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- External Artificial Organs (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/712,038 US4680171A (en) | 1985-03-15 | 1985-03-15 | Visualization of a bloodstream circulation with biodegradable microspheres |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO860952L true NO860952L (no) | 1986-09-16 |
Family
ID=24860555
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO860952A NO860952L (no) | 1985-03-15 | 1986-03-13 | Fremgangsmaate for visualisering av en arterie-sirkulasjon og middel for utfoerelse av denne. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US4680171A (fr) |
| EP (1) | EP0194644B1 (fr) |
| JP (1) | JPS61267529A (fr) |
| AU (1) | AU589606B2 (fr) |
| CA (1) | CA1288335C (fr) |
| DE (1) | DE3688799T2 (fr) |
| HK (1) | HK148795A (fr) |
| IL (1) | IL78119A0 (fr) |
| MX (1) | MX173250B (fr) |
| NO (1) | NO860952L (fr) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5186922A (en) * | 1985-03-15 | 1993-02-16 | See/Shell Biotechnology, Inc. | Use of biodegradable microspheres labeled with imaging energy constrast materials |
| US4820732A (en) * | 1985-10-04 | 1989-04-11 | The Upjohn Company | Method and compositions for reducing dysfunction in angioplasty procedures |
| CS255758B1 (en) * | 1985-12-11 | 1988-03-15 | Frantisek Rypacek | Preparat for the diagnostic of transportion function of oviduct and process for preparing thereof |
| US5019370A (en) * | 1989-07-10 | 1991-05-28 | University Of Kentucky Research Foundation | Biodegradable, low biological toxicity radiographic contrast medium and method of x-ray imaging |
| US5407659A (en) * | 1991-10-22 | 1995-04-18 | Mallinckrodt Medical, Inc. | Treated calcium/oxyanion-containing particles for medical diagnostic imaging |
| US5344640A (en) * | 1991-10-22 | 1994-09-06 | Mallinckrodt Medical, Inc. | Preparation of apatite particles for medical diagnostic imaging |
| US5340564A (en) * | 1992-12-10 | 1994-08-23 | Sterling Winthrop Inc. | Formulations comprising olin 10-G to prevent particle aggregation and increase stability |
| US5520904A (en) * | 1995-01-27 | 1996-05-28 | Mallinckrodt Medical, Inc. | Calcium/oxyanion-containing particles with a polymerical alkoxy coating for use in medical diagnostic imaging |
| US6071300A (en) * | 1995-09-15 | 2000-06-06 | Sub-Q Inc. | Apparatus and method for percutaneous sealing of blood vessel punctures |
| US20070092563A1 (en) | 1996-10-01 | 2007-04-26 | Abraxis Bioscience, Inc. | Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof |
| US20010003580A1 (en) | 1998-01-14 | 2001-06-14 | Poh K. Hui | Preparation of a lipid blend and a phospholipid suspension containing the lipid blend |
| FR2784580B1 (fr) * | 1998-10-16 | 2004-06-25 | Biosepra Inc | Microspheres de polyvinyl-alcool et procedes de fabrication de celles-ci |
| US6203778B1 (en) | 1998-12-08 | 2001-03-20 | The Regents Of The University Of California | Particulate radiopaque contrast agent for diagnostic imaging and microvascular characterization |
| DE60130743T2 (de) | 2000-03-24 | 2008-07-17 | Biosphere Medical, Inc., Rockland | Mikrokugeln zur aktiven embolisierung |
| US20030212022A1 (en) * | 2001-03-23 | 2003-11-13 | Jean-Marie Vogel | Compositions and methods for gene therapy |
| US20060009694A1 (en) * | 2004-05-17 | 2006-01-12 | Yousefzadeh David K | Methods of attenuating internal radiation exposure |
| ES2568782T3 (es) | 2005-05-09 | 2016-05-04 | Biosphere Medical, S.A. | Composiciones y métodos de uso de microesferas y agentes de contraste no iónicos |
| EP1986707A2 (fr) * | 2006-01-30 | 2008-11-05 | Surgica Corporation | Particules d'embolisation intravasculaire compressible, procedes connexes et systemes d'administration |
| EP2368581B1 (fr) * | 2006-01-30 | 2018-08-29 | Biosphere Medical, Inc. | Particules d'embolisation intravasculaire poreuses et procédés apparentés |
| WO2010062678A2 (fr) * | 2008-10-30 | 2010-06-03 | David Liu | Échafaudages biocompatibles poreux microsphériques, et procédés et appareil pour la fabrication de ces échafaudages |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3663687A (en) * | 1968-06-26 | 1972-05-16 | Minnesota Mining & Mfg | Biodegradable parenteral microspherules |
| US3984571A (en) * | 1970-03-10 | 1976-10-05 | E. R. Squibb & Sons, Inc. | Hydrocolloid containing liquid carrier for a diagnostic or therapeutic agent |
| SE420565B (sv) * | 1974-06-06 | 1981-10-19 | Pharmacia Ab | Hjelpmedel for intravaskuler administraring for anvendning i samband med intravaskuler administrering av en losning eller en suspension av ett diagnostiseringsmedel |
| DE2803869C2 (de) * | 1978-01-30 | 1983-12-29 | Ethicon, Inc., 08876 Somerville, N.J. | Injizierbare Embolisations- und Okklusionslösung |
| US4192859A (en) * | 1978-09-29 | 1980-03-11 | E. R. Squibb & Sons, Inc. | Contrast media containing liposomes as carriers |
| CH641682A5 (en) * | 1978-10-05 | 1984-03-15 | Daeniker Felix | X-ray contrast medium |
| JPS55100312A (en) * | 1979-01-25 | 1980-07-31 | Toshiro Wada | Contrast medium for blood vessel |
| US4247406A (en) * | 1979-04-23 | 1981-01-27 | Widder Kenneth J | Intravascularly-administrable, magnetically-localizable biodegradable carrier |
| JPS5832829A (ja) * | 1981-08-22 | 1983-02-25 | Green Cross Corp:The | 血管造影剤 |
| US4492720A (en) * | 1983-11-15 | 1985-01-08 | Benjamin Mosier | Method of preparing microspheres for intravascular delivery |
| SE463651B (sv) * | 1983-12-21 | 1991-01-07 | Nycomed As | Diagnostikum och kontrastmedel |
-
1985
- 1985-03-15 US US06/712,038 patent/US4680171A/en not_active Expired - Fee Related
-
1986
- 1986-03-06 AU AU54384/86A patent/AU589606B2/en not_active Ceased
- 1986-03-11 IL IL78119A patent/IL78119A0/xx not_active IP Right Cessation
- 1986-03-11 DE DE86103233T patent/DE3688799T2/de not_active Expired - Fee Related
- 1986-03-11 EP EP86103233A patent/EP0194644B1/fr not_active Expired - Lifetime
- 1986-03-13 CA CA000504074A patent/CA1288335C/fr not_active Expired - Lifetime
- 1986-03-13 NO NO860952A patent/NO860952L/no unknown
- 1986-03-14 JP JP61055154A patent/JPS61267529A/ja active Pending
- 1986-03-17 MX MX001897A patent/MX173250B/es unknown
-
1995
- 1995-09-14 HK HK148795A patent/HK148795A/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0194644B1 (fr) | 1993-08-04 |
| DE3688799D1 (de) | 1993-09-09 |
| EP0194644A3 (en) | 1987-09-30 |
| AU589606B2 (en) | 1989-10-19 |
| AU5438486A (en) | 1986-09-18 |
| IL78119A0 (en) | 1986-07-31 |
| JPS61267529A (ja) | 1986-11-27 |
| EP0194644A2 (fr) | 1986-09-17 |
| CA1288335C (fr) | 1991-09-03 |
| US4680171A (en) | 1987-07-14 |
| DE3688799T2 (de) | 1993-11-18 |
| MX173250B (es) | 1994-02-14 |
| HK148795A (en) | 1995-09-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5186922A (en) | Use of biodegradable microspheres labeled with imaging energy constrast materials | |
| NO860952L (no) | Fremgangsmaate for visualisering av en arterie-sirkulasjon og middel for utfoerelse av denne. | |
| Wagner et al. | Regional pulmonary blood flow in man by radioisotope scanning | |
| Takagi et al. | Detection of a residual nidus by surgical microscope-integrated Intraoperative near-infrared indocyanine green videoangiography in a child with a cerebral arteriovenous malformation: Case report | |
| Qanadli et al. | Helical CT phlebography of the superior vena cava: diagnosis and evaluation of venous obstruction. | |
| Chuang et al. | Sheath needle for liver biopsy in high-risk patients. | |
| Dix et al. | Comparison of intravenous coronary angiography using synchrotron radiation with selective coronary angiography | |
| JPH0425934B2 (fr) | ||
| RU96122883A (ru) | Физиологически совместимые эмульсии, содержащие перфторуглеводородные эфиргидриды, и способы их использования | |
| WO2003075961A2 (fr) | Supports et procedes d'amelioration d'imagerie medicale | |
| JP7357060B2 (ja) | 血管造影の改善された方法 | |
| US8992888B2 (en) | Radiographic contrast agent for postmortem, experimental and diagnostic angiography | |
| Tomoda et al. | Evaluation of left atrial thrombus with computed tomography | |
| JP2007507535A (ja) | 医療および診断処置に用いられる造影剤ならびにその使用方法 | |
| Monaghan et al. | Digital subtraction contrast echocardiography: a new method for the evaluation of regional myocardial perfusion. | |
| Miller et al. | Intraoperative angioscopy: principles of irrigation and description of a new dedicated irrigation pump | |
| JP2009023929A (ja) | 微小循環構築の血管種別選択的造影剤および造影方法 | |
| Zhang et al. | Anatomical investigation of the sinus node artery using dual-source computed tomography | |
| Bunker SR et al. | Femoral intraarterial digital angiography: An outpatient procedure | |
| Fye | Coronary arteriography--it took a long time! | |
| Meier et al. | Detection of postoperative granulation tissue with an ICG-enhanced integrated OI-/X-ray System | |
| Kumazaki | Development of rotational digital angiography and new cone-beam 3D image: Clinical value in vascular lesions | |
| Grossman et al. | Transmission computed tomographic diagnosis of experimentally produced acute pulmonary vascular occlusion in the dog | |
| Ritman et al. | A tomographic approach to intravenous coronary arteriography | |
| Chung et al. | Angiography of congenital heart disease |